Rx Only Syrup / suspension • GI mucosal cytoprotective agent
✓ Medically Reviewed Monograph

Sucralfate

Also known as / Synonyms: Sucralfate, Basic aluminum sucrose sulfate

Gastrointestinal cytoprotective medicine forming a protective barrier over ulcers to promote mucosal healing.

Medically reviewed by Dr. Lisa Matthews, PharmD BCPS · Clinical Pharmacist
Written by 4mg Clinical Pharmacology Team Last reviewed ✓ Clinically Verified
📋

Clinical Snapshot & Specifications

Generic Name: Sucralfate
Active Ingredient: Sucralfate
Dosage Form: Syrup / suspension
Available Strengths: 1000 mg/5 mL (1 g/5 mL) oral suspension; 1000 mg tablets
Prescription Status: Prescription only (Schedule H / verified)
Approved Routes:
Oral
Popular Verified Brands:
Sucrafil Carafate Sucral Macralfate Sparacid (India)
Regulatory Standards: CDSCO approved; Schedule H prescription medicine. Locally acting mucosal protective agent.
🎯

Approved Indications & Medical Uses

  • Short-term treatment of active duodenal ulcer.
  • Maintenance therapy for duodenal ulcer patients at reduced dosage.
  • Gastric mucosal injury, bile reflux gastritis, and aphthous oral ulcerations.
🚫

Contraindications (Do Not Use If…)

Known hypersensitivity to sucralfate or aluminum salts.

🛡️

Important Clinical Precautions & Warnings

  • Aluminum accumulation and toxicity: caution in chronic renal failure or hemodialysis patients due to impaired aluminum excretion.
  • Bezoar formation: reported in patients with delayed gastric emptying, enteral feeding tubes, or severe motility disorders.
  • Drug absorption interference: binds to concurrently ingested drugs; space sucralfate at least 2 hours apart from all other medications.
  • Timing of administration: must be taken on an empty stomach (1 hour before meals and at bedtime) to form protective paste over ulcers.

Special Populations (Paediatric & Geriatric Care)

Pediatric: Safety and effectiveness in children have not been established. Elderly: Prone to constipation; ensure adequate fluid intake.

⚡

Side Effects & Adverse Reactions

ℹ️ Common Side Effects (Usually Mild)

Constipation (most frequent, ~2%), dry mouth, nausea, vomiting, flatulence, and indigestion.

🚨 Serious Side Effects — Seek Urgent Medical Care

Esophageal or gastrointestinal bezoar obstruction, severe aluminum neurotoxicity/encephalopathy in end-stage renal disease, and hypersensitivity reactions.

Action: Discontinue medication and seek immediate medical attention or call emergency services if any serious symptom occurs.

🔄

Drug, Food & Substance Interactions

  • Fluoroquinolones (ciprofloxacin, levofloxacin): severe binding reduces antibiotic bioavailability by up to 90%; space by >= 2 hours.
  • Thyroid hormone (levothyroxine): reduced absorption leading to hypothyroidism.
  • Digoxin, phenytoin, warfarin, ketoconazole: decreased absorption; administer at least 2 hours prior to sucralfate.
  • Antacids: administer at least 30 minutes before or after sucralfate (acidic pH required for sucralfate activation).
🤰

Pregnancy & Lactation Clinical Safety

Pregnancy Safety:

Use with caution — see notes

Minimally absorbed systemically; considered relatively safe during pregnancy when clinically indicated, but physician evaluation is advised.

Lactation & Breastfeeding:

Use with caution — see notes

Due to negligible systemic absorption, transfer into breast milk is minimal. Unlikely to adversely affect a nursing infant.

📦

Storage, Administration & Overdose Protocol

🌡️ Recommended Storage:

Store suspension and tablets below 30°C. Protect from freezing. Shake suspension well before each use.

⏱️ Missed Dose Protocol:

Take 1 g four times daily on an empty stomach (1 hour before each meal and at bedtime). If missed, take as soon as remembered on an empty stomach, or skip if next dose is due.

📚

Clinical Sources & Regulatory References

Statutory drug monograph citations and regulatory databases consulted for clinical synthesis.

Every clinical monograph on 4mg.in is continuously cross-referenced against official pharmacopoeias, national formulary compendia, and statutory regulatory filings to guarantee therapeutic precision:

🏛️ CDSCO (Govt. of India)

Central Drugs Standard Control Organisation, Ministry of Health and Family Welfare. Evaluated for approved indications, Schedule H/H1 status, and National List of Essential Medicines (NLEM).

CDSCO Official Portal →
🇺🇸 U.S. FDA / DailyMed

U.S. Food and Drug Administration Approved Prescribing Information, Package Inserts, and Pharmacovigilance Black Box Warnings repository via NLM DailyMed.

Search FDA Labels on DailyMed →
🌐 World Health Organization

WHO Model List of Essential Medicines (23rd List) and WHO Collaborating Centre for Drug Statistics Methodology (Anatomical Therapeutic Chemical - ATC / DDD Index).

WHO Essential Medicines Registry →
🔬 PubMed / NLM

National Center for Biotechnology Information (NCBI). Peer-reviewed clinical trials, bioavailability investigations, and Cochrane systematic reviews.

Query PubMed Studies for Sucralfate →
Suggested Monograph Citation:

4mg Clinical Pharmacology Team. Sucralfate Monograph: Uses, Dosage, Contraindications & Interactions. Medically reviewed by licensed clinical editors. 4mg.in, 2026. Available at: https://4mg.in/medicines/sucralfate/

🛡️
Clinical & Legal Disclaimer: The clinical monographs and drug information published on 4mg.in are strictly intended for educational, clinical reference, and informational utility. They do not constitute personalized medical advice, diagnosis, or treatment regimens. Always seek the advice of a registered physician or licensed pharmacist regarding specific clinical conditions, prescription dosages, and potential contraindications. Review our comprehensive Editorial & Clinical Fact-Checking Policy.